Biologics Manufacturing
Accelerating Sequence Variant Analysis in Biologic Drug Development
Samsung Biologics
Biologics Manufacturing
Capabilities, tools and techniques to overcome complexities and address limitations and risks.
A cutting-edge LC-MS/MS methodology reduces sequence variant analysis timelines from 6–8 weeks to 1–2 weeks, ensuring absence of genetic mutations during cell culture.
A cutting-edge LC-MS/MS methodology reduces sequence variant analysis timelines from 6–8 weeks to 1–2 weeks, ensuring absence of genetic mutations during cell culture.
Why Sequence Variants Matter
Unintended amino acid changes can affect safety and efficacy and must be controlled.
Faster LC-MS/MS Workflows
Streamlined sample preparation and analysis cut turnaround from weeks to days.
Supporting Cell Line Selection
Quicker results speed clone selection and reduce program risk.
Download This White Paper
Biotechnology Media Insights
Continue to Biotechnology Media Insights to access this white paper.